Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa

By Altundag Kadri   Altundag Ozden   Baptista Mauricio   Atik Mustafa  

Breast Cancer Research and Treatment, Vol. 97, Iss. 2, 2006-05 ,pp. : 221-221

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy for Breast Cancer: Does Pretreatment Axillary Nodal Staging Improve Decision Making?

By Batsis Charalabos  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 1063-1064

Springer Publishing Company

Access to resources Recommend Favorite

Does Neoadjuvant Treatment for Gastric Cancer Patients with Positive Peritoneal Cytology at Staging Laparoscopy Improve Survival?

By Badgwell Brian  

Annals of Surgical Oncology, Vol. 15, Iss. 10, 2008-10 ,pp. : 2684-2691

Springer Publishing Company

Access to resources Recommend Favorite

Can bone markers guide more effective treatment of bone metastases from breast cancer?

By Clemons Mark   Cole David   Gainford Mary  

Breast Cancer Research and Treatment, Vol. 97, Iss. 1, 2006-05 ,pp. : 81-90

Springer Publishing Company

Access to resources Recommend Favorite

Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?

By Alkan Ali  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1430-1430

Humana Press, Inc

Access to resources Recommend Favorite